Effect of Standard Dose Versus Risk Adapted Melphalan Conditioning on Outcomes in Systemic AL Amyloidosis Patients Undergoing Frontline Autologous Stem Cell Transplant Based on Revised Mayo Stage
Year: 2016
Type: article
Study design: Observational Study
Source: Blood
Authors: Nidhi Tandon, Surbhi Sidana, Angela Dispenzieri, Morie A. Gertz, Francis K Buadi, Martha Q. Lacy, David Dingli, Amie Fonder, Suzanne R. Hayman, Miriam Hobbs, Prashant Kapoor, Wilson I Gonsalves, Yi L. Hwa, Robert A. Kyle, Ronald S. Go, John A Lust, Nelson Leung, Stephen J. Russell, Steven R. Zeldenrust, S. Vincent Rajkumar, Shaji Kumar
Institution: Mayo Clinic
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2753463956